G-protein coupled receptors (GPCR) represent a large family of receptors, w
hich have been and still are targets of choice for drug discovery. Among th
e different tools offered to medicinal chemists to design potent and select
ive GPCR agonists or antagonists, the bivalent-ligand approach (which consi
sts of bridging two pharmacophores in a single ligand) has proven to be, in
many cases, valuable to improve potency, selectivity, intrinsic activity a
nd in vivo profile of the corresponding monomer. This review will focus on
GPCR ligands in drug research with particular emphasis on the most recent p
rogress in the field.